section name header

Y-Site Injection Compatibility (1:1 Mixture)

Cefotaxime sodium

(Mfr: HO)(Conc: 20 mg/mLa)

I

Hetastarch in sodium chloride 0.9%

(Mfr: DCC)(Conc: 6%)

Remarks:

Small crystals form immediately after mixing and persist for 4 hr

Ref:

1313